Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | +6.20% | -31.84% | -57.72% |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Apr. 22 | Sector Update: Health Care | MT |
Business Summary
Number of employees: 22
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 15-12-31 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-02 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Daniel Trepanier
PRN | Corporate Officer/Principal | - | 19-10-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 13-05-14 |
Timothy Block
BRD | Director/Board Member | 69 | 13-11-25 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 22-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,688 | 0 | 0 | 99.69 % |
Stock B | 1 | 5,472,451 | 5,455,670 ( 99.69 %) | 0 | |
Stock C | 0 | 85,581 | 0 | 0 |
Company contact information
Hepion Pharmaceuticals, Inc.
399 Thornall Street 1st Floor
08837, Edison
+732 902 4000
http://www.hepionpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.72% | 7.06M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- HEPA Stock
- Company Hepion Pharmaceuticals, Inc.